Emergent BioSolutions Inc. — Director's Dealing 2017

Dec 13, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2017-12-12

Reporting Person: Richard Ronald (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-12-12	Common Stock	M	23681	$10.64	Acquired	47091	Direct
2017-12-12	Common Stock	S	23681	$45.0245	Disposed	23410	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-12-12	Employee Stock Option (Right to buy)	$10.64	M	23681	Disposed	2019-05-21	Common Stock (23681)	Direct

Footnotes

F1: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Richard.

F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $45.17, inclusive.

F3: Consists of an option granted under the company's stock incentive plan as amended and restated.

F4: The option grant is fully vested.